Characterization and immunogenicity assessment of MERS-CoV pre-fusion spike trimeric oligomers as vaccine immunogen
Middle East respiratory syndrome coronavirus (MERS-CoV) is a lethal beta-coronavirus that emerged in 2012. The virus is part of the WHO blueprint priority list with a concerning fatality rate of 35%. Scientific efforts are ongoing for the development of vaccines, anti-viral and biotherapeutics, whic...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis Group
2024-12-01
|
| Colección: | Human Vaccines & Immunotherapeutics |
| Materias: | |
| Acceso en línea: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2351664 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|